Publication Name	World Journal of Gastroenterology
Manuscript ID	104038
Country	China

Received	2025-01-22 08:28
Peer-Review Started	2025-01-22 08:28
To Make the First Decision
Return for Revision	2025-03-19 23:00
Revised	2025-03-27 12:26
Second Decision	2025-05-07 02:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-05-07 05:56
Articles in Press	2025-05-07 05:56
Publication Fee Transferred	2025-03-31 12:48
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-05-20 07:14
Publish the Manuscript Online	2025-05-28 07:32

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Case Report
Article Title	Upadacitinib for ulcerative colitis and pyoderma gangrenosum in a patient with schizophrenia on long-term risperidone: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Sheng-Duo He and Yu Tian
ORCID	Author(s) ORCID Number Yu Tian http://orcid.org/0000-0003-2516-3554
Funding Agency and Grant Number
Corresponding Author	Yu Tian, Chief Physician, MD, Department of Gastroenterology, Peking University First Hospital, N0.8 xishiku street, xicheng district, Beijing 100034, China. tianyu@medmail.com.cn
Key Words	Ulcerative colitis; Schizophrenia; Risperidone; Pyoderma gangrenosum; Upadacitinib; Case report
Core Tip	Due to the potential anti-inflammatory effect of risperidone via the tumor necrosis factor pathway, patients with new-onset ulcerative colitis (UC) who have been receiving long-term risperidone cannot achieve a good therapeutic effect with anti-tumor necrosis factor therapy. We report the successful treatment of a patient with UC combined with pyoderma gangrenosum using upadacitinib, with no adverse events during the 6-month follow-up period.
Publish Date	2025-05-28 07:32
Citation	<p>He SD, Tian Y. Upadacitinib for ulcerative colitis and pyoderma gangrenosum in a patient with schizophrenia on long-term risperidone: A case report. <i>World J Gastroenterol</i> 2025; 31(20): 104038</p>
URL	https://www.wjgnet.com/1007-9327/full/v31/i20/104038.htm
DOI	https://dx.doi.org/10.3748/wjg.v31.i20.104038

Full Article (PDF)	WJG-31-104038-with-cover.pdf
CARE Checklist–2016	104038-CARE-Checklist-2016.pdf
Manuscript File	104038_Auto_Edited_081922.docx
Answering Reviewers	104038-answering-reviewers.pdf
Audio Core Tip	104038-audio.MP3
Conflict-of-Interest Disclosure Form	104038-conflict-of-interest-statement.pdf
Copyright License Agreement	104038-copyright-assignment.pdf
Signed Consent for Treatment Form(s) or Document(s)	104038-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate	104038-non-native-speakers.pdf
Peer-review Report	104038-peer-reviews.pdf
Scientific Misconduct Check	104038-scientific-misconduct-check.png
Scientific Editor Work List	104038-scientific-editor-work-list.pdf
CrossCheck Report	104038-crosscheck-report.pdf